FundedIQ
Biotechnology

Biomatter: Funding, Investors & Team (Oct 2026)

Biomatter is a company specializing in synthetic biology that creates new proteins for medical and sustainable manufacturing purposes. The company has pioneered the Intelligent Architecture platform, which aims to overcome the constraints of current engineering methods and pave the way for innovative protein design and development.

www.biomatter.ai LinkedIn Vilnius, Lithuania 11-50 employees
Biotechnology Pharmaceutical B2B
Total raised
$7.1M
Rounds
1
Latest
Seed
Aug 2024

Biomatter has raised $7.1M across 1 funding round on record, the most recent a Seed of $7.1M announced in Aug 2024.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Biomatter Company Profile and Key Stats

Total funding raised
$7.1M
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$7.1M in Aug 2024
Employees
11-50
reported band
Headquarters
Vilnius, Lithuania

Latest funding round on record: Aug 2024.

Biomatter Funding Rounds

Date
Round
Amount
Seed
$7.1M

Biomatter Founders and Leadership Team

Name
Role
Contact
Vykintas Jauniskis
Founder
Locked

Contact details for the Biomatter team: 1 of 1 has an email address on file.

Start 14-day free trial →

Biomatter Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
103
$2.4M
17,054
$3.1M

Biomatter's latest round of $7.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Biomatter in Biotechnology and Vilnius

Companies Similar to Biomatter

Atrandi Biosciences is a privately owned biotechnology company that specializes in advanced single-cell…

Series A $25.0M

Biohifas employs the power of mycelium and valorizes industrial side streams into the food. We are developing…

Undisclosed round $30k
Series B $150M

BioLinker is a creation of manufactured science, protein blend packs, and protein.

Undisclosed round $1.7M

WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs…

Series B $26.0M

Tydra Labs is a biotechnology company that transforms crustacean shell waste into chitin and bio-products.

Seed $420k

M-Based develops new alternative material technologies using mushrooms. 🍄 We consider environmental…

Seed $700k

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Turning biomass residues into fit-for-purpose microbial fertilizers, biostimulants and biocontrols.

Series A —

R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…

Series A $3.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Biomatter Funding FAQs

What does Biomatter do?

Biomatter is a company specializing in synthetic biology that creates new proteins for medical and sustainable manufacturing purposes. The company has pioneered the Intelligent Architecture platform, which aims to overcome the constraints of current engineering methods and pave the way for innovative protein design and development.

How much funding has Biomatter raised?

Biomatter has raised $7.1M across 1 round on record. The most recent is a Seed of $7.1M announced in Aug 2024.

When did Biomatter last raise funding?

Biomatter's most recent funding round on record is a Seed of $7.1M, announced in Aug 2024.

Who founded Biomatter?

FundedIQ lists Vykintas Jauniskis (Founder) at Biomatter.

Where is Biomatter headquartered?

Biomatter is based in Vilnius, Vilniaus Apskritis, Lithuania.

How many employees does Biomatter have?

Biomatter is in the 11-50 employee band.

How does Biomatter's funding compare to other Biotechnology startups?

Biomatter's latest round of $7.1M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Biomatter Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Biomatter is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.